The scientific field is already doing a ton - Neuro is one of the most active areas of research right now. Behind COVID that is, currently pretty much everythin

The scientific field is already doing a ton - Neuro is one of the most active areas of research right now. Behind COVID that is, currently pretty much everything is on hold for COVID. Pre-COVID however oncology and neuroscience were already among the biggest focus areas of research. One of the basic problems is that we lack a fundamental understanding of how the disease works, so throwing more money at it gets diminishing returns beyond a point. It's like the war on cancer in the 1970s. We threw tons of money at cancer research which basically consisted of trying more newer combination chemotherapies in greater amounts and in new permutations trying to find the combination of chemicals that would eradicate all cancers. That only got us so far. However, at the same time, with a lot less funding and public support, scientists were making headway at understanding cancer not necessarily as a cellular disease, but as a genetic disease. By realizing that cancer is driven by genetic mutations, those scientists paved the way for the vastly more effective treatments and rush of immunoconcology/personalized/targeted therapies we see today. Throwing more money at Alzheimers at this point basically all but guarantees more trials of amyloid beta inhibitors at earlier stages and with bigger trials. We've already burnt tens of billions of dollars on that. The basic research to understand the disease is actually cheaper in the long run than running more of those clinical trials, but it's a stochastic, slow process with unclear goals and timelines.